Maxcyte (MXCT) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Maxcyte (MXCT) over the last 5 years, with Q3 2025 value amounting to 0.16.

  • Maxcyte's Asset Utilization Ratio fell 1286.7% to 0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year decrease of 1286.7%. This contributed to the annual value of 0.15 for FY2024, which is 224.88% up from last year.
  • Latest data reveals that Maxcyte reported Asset Utilization Ratio of 0.16 as of Q3 2025, which was down 1286.7% from 0.16 recorded in Q2 2025.
  • Over the past 5 years, Maxcyte's Asset Utilization Ratio peaked at 0.18 during Q3 2024, and registered a low of 0.12 during Q4 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.15, with a median of 0.15 in 2022.
  • In the last 5 years, Maxcyte's Asset Utilization Ratio plummeted by 1621.78% in 2022 and then surged by 2891.92% in 2024.
  • Maxcyte's Asset Utilization Ratio (Quarter) stood at 0.12 in 2021, then rose by 28.02% to 0.15 in 2022, then fell by 0.08% to 0.15 in 2023, then rose by 2.55% to 0.16 in 2024, then rose by 0.39% to 0.16 in 2025.
  • Its Asset Utilization Ratio was 0.16 in Q3 2025, compared to 0.16 in Q2 2025 and 0.16 in Q1 2025.